ISLAMABAD: Former Prime Minister and PTI founder Imran Khan underwent a follow-up eye examination at the Pakistan Institute of Medical Sciences (PIMS) on Wednesday, where doctors reported signs of improvement following continued treatment.
According to hospital officials, Khan was administered the fourth dose of an Anti-VEGF intravitreal injection, a procedure commonly used to treat retinal conditions by inhibiting abnormal blood vessel growth in the eye. The treatment is typically recommended for diseases such as age-related macular degeneration or other vision-impairing disorders.
Specialists conducted a detailed ophthalmic evaluation, including Optical Coherence Tomography (OCT), a non-invasive imaging test used to assess the retina. Medical experts noted improvement in the OCT results, indicating a positive response to the ongoing treatment.
The PIMS administration stated that the procedure was carried out after obtaining informed consent from the patient. Officials emphasized that all medical protocols were strictly followed, ensuring the patient was fully briefed about the process beforehand.
The treatment was conducted in a controlled environment within the operation theatre, under standard monitoring and supervision. Following the procedure, Imran Khan was discharged with post-treatment care instructions, follow-up guidelines, and relevant medical documentation.
Hospital authorities reiterated that the patient’s condition is being managed through a structured treatment plan, and further follow-ups will be conducted as required to monitor progress.
The update on Khan’s health comes amid continued public and political interest, with supporters closely watching developments related to his well-being. Medical experts, however, stress that such treatments often require multiple doses over time, and gradual improvement is a positive sign in managing retinal conditions.
